Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Accept all cookies Reject all non-essential cookies Find out more

Search results

Showing results for

Oxford spin-out Base Genomics is acquired by early cancer detection company Exact Sciences.

Vaccines for cancer prevention

The Suspected CANcer (SCAN) pathway

Accelerating diagnosis in people with non-specific symptoms of cancer

DeLIVER: Early detection of hepatocellular liver cancer

This CRUK-funded programme led by Professor Ellie Barnes is characterising the pre-cancerous liver microenvironment and integrating multi-modal technologies to develop and refine strategies for translatable liver cancer risk prediction and early detection.

Liquid biopsy tests detecting cancer-derived DNA

Oxford researchers are developing a range of liquid biopsy tests for earlier cancer detection, including four that rely on the detection of cancer-derived DNA.

Similar stories